Results 71 to 80 of about 22,154 (275)

Chronic Productive Cough in an Immunosuppressed Patient due to Biologics: A Rare Case of Bordetella bronchiseptica Pulmonary Infection

open access: yesRespirology Case Reports, Volume 14, Issue 1, January 2026.
This case illustrates features of ground glass changes on radiology in a patient who was immunosuppressed with biologics. Microbiology confirmed infection with Bordetella bronchiseptica, highlighting the importance of looking for atypical infections in patients receiving biologics and the importance of pet ownership history.
Debashree Banerjee   +5 more
wiley   +1 more source

Thymectomy for myasthenia gravis [PDF]

open access: yesPostgraduate Medical Journal, 1998
SummaryThe pathophysiological role of the thymus in myasthenia gravis, and the mechanism of therapeutic effect of thymectomy, are incompletely understood. Nevertheless, thymectomy is a valuable treatment modality in selected patients with generalised myasthenia gravis.
J D, Urschel, R P, Grewal
openaire   +2 more sources

Neoadjuvant Glucocorticoids Facilitate Resection in Advanced B‐Type Thymomas: A Propensity‐Matched Analysis of Surgical and Survival Outcomes

open access: yesThoracic Cancer, Volume 17, Issue 1, January 2026.
Neoadjuvant glucocorticoids facilitated less invasive and more complete resection of advanced B‐type thymomas, leading to reduced operative morbidity and improved progression‐free survival compared to upfront surgery. This study supports a novel downstaging strategy for this challenging disease.
Zhen Yu   +7 more
wiley   +1 more source

Myasthenia. Surgical treatment and its effectiveness

open access: yesActa Biomedica Scientifica, 2012
The article reviews the problems of diagnostics and. treatment of myasthenia. The authors consider that thymectomy in modern conditions is founded, expedient and. safe for the patients surgery at the treatment of different forms of myasthenia.
M. B. Skvortsov, A. I. Smolin
doaj  

Thymic hyperplasia as a rare etiology of pure red cell aplasia: A case report [PDF]

open access: yesVojnosanitetski Pregled
Introduction. Thymic hyperplasia is a rare condition caused by an increase in cellular thymic mass and, in some cases, is associated with autoimmune diseases, such as pure red cell aplasia (PRCA).
Arsenović Isidora   +6 more
doaj   +1 more source

Thymectomy for treatment of anti-NMDA receptor encephalitis [PDF]

open access: bronze, 2022
Benjamin A. Palleiko   +3 more
openalex   +1 more source

Thymectomy for myasthenia gravis [PDF]

open access: yesThorax, 1972
Between 1951 and 1971 thymectomy was performed on 41 patients with myasthenia gravis. They were selected from a total group of 95 myasthenic patients receiving anticholinesterase therapy. The criteria for selecting patients for thymectomy and the assessment of their progress after operation are described.
F R, Edwards, A, Wilson
openaire   +2 more sources

Relationship between immune reactivity and developement of thymic lymphoma by N,N'-dimethylnitrosourea in C3Hf-Bi mice [PDF]

open access: yes, 1971
By subcutaneous inoculation of N, N'-dimethylnitrosourea to adult male C3Hf/Bi mice once a week for 10 consecutive weeks the authors studied the correlation between immunological functions and histological changes in lymphatic tissues at the latent ...
Motoi, Makoto   +2 more
core   +1 more source

Evaluating the Real‐World Safety of Ravulizumab in Generalized Myasthenia Gravis: Insights From a Detailed Analysis of FAERS Data

open access: yesJournal of Clinical Pharmacy and Therapeutics, Volume 2026, Issue 1, 2026.
Background Ravulizumab represents the inaugural long‐acting complement C5 inhibitor that has received approval in various countries around the globe for individuals diagnosed with generalized myasthenia gravis (gMG) who are positive for anti‐acetylcholine receptor antibodies.
Yakun Wang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy